[
    {
        "chunk_id": 1,
        "original_chunk": "<figure>\n\n<!-- PageHeader=\"T Instructions for Use\" -->\n\n</figure>\n\n\nen\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\nKnotless Tissue Control Device\nAntibacterial\nUndyed Monofilament Synthetic\nAbsorbable Unidirectional Device\n\n\n# Description\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Knotless Tissue Control Device is a sterile,\nantibacterial monofilament, synthetic absorbable device composed of 100\nweight percent copolymer of glycolide and E-caprolactone. The empirical\nformula of the copolymer is (C, H, O,)_(C H O) . Poliglecaprone 25 copolymer\nhas been found to be nonpyrogenic and elicits only a slight tissue reaction\nduring absorption.",
        "translated_back_chunk": "<figure>\n\n<!-- PageHeader=\"T Use Instructions\" -->\n\n</figure>\n\n\nen\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\nKnotless Tissue Control Device\nAntibacterial\nUndyed Synthetic Monofilament\nUnidirectional Absorbable Device\n\n\n# Description\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus knotless tissue control device is a sterile antibacterial synthetic absorbable monofilament device, composed of 100 percent by weight of glycolide and E-caprolactone copolymer. The empirical formula of the copolymer is (C, H, O,)_(C H O). The poliglecaprone 25 copolymer has been found to be non-pyrogenic and only causes a mild tissue reaction during absorption.",
        "similarity_score": 0.9937
    },
    {
        "chunk_id": 2,
        "original_chunk": "STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device contains IRGACAREÂ®+ MP\n(triclosan), a broad spectrum antibacterial agent, at no more than 2360 Âµg/m.\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device, Variable Loop Design consists\nof barbed suture material, armed with a surgical needle on one end and a\nfixation loop at the opposite end. STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device\nis designed to anchor with a closed loop at one end and a unidirectional barbed\nsection on the other end. STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device barbs\nare oriented in one direction to allow tissue approximation without the need\nto tie surgical knots.",
        "translated_back_chunk": "The STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device contains IRGACAREÂ®+ MP (triclosan), a broad-spectrum antibacterial agent, with no more than 2360 Âµg/m. The STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device, with a variable loop design, consists of barbed suture material equipped with a surgical needle at one end and a fixation loop at the opposite end. The STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is designed to anchor with a closed loop at one end and a unidirectional barbed section at the other end. The barbs of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device are oriented in one direction to allow the approximation of tissues without the need for tying surgical knots.",
        "similarity_score": 0.9909
    },
    {
        "chunk_id": 3,
        "original_chunk": "While the formation of barbs in STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device\nreduces the tensile strength relative to non-barbed suture material of the same\nsize, tying of knots in non-barbed suture materials also reduces their effective\nstrengths. For this reason, the strength of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\nDevice can be compared to United States Pharmacopeia (USP) knot strength\nof non-barbed sutures. USP designations for diameter are used to describe\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device suture material after barbing,\nexcept for minor variation in suture diameter with a maximum overage of\n0.1 mm.\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available in a range of gauge\nsizes and lengths, attached to needles of various types and sizes, and in\npresentations as described in the How Supplied section.",
        "translated_back_chunk": "While the formation of barbs in STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device reduces tension resistance compared to non-barbed suture material of the same size, knot tying in non-barbed suture materials also reduces their effective strength. For this reason, the strength of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device can be compared to the knot strength of United States Pharmacopeia (USP) of non-barbed sutures. USP designations for diameter are used to describe the suture material of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device after barbing, except for a minor variation in the diameter of the suture with a maximum excess of 0.1 mm.\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available in a range of gauge sizes and lengths, attached to needles of various types and sizes, and in presentations as described in the How it is Supplied section.",
        "similarity_score": 0.9953
    },
    {
        "chunk_id": 4,
        "original_chunk": "The European Pharmacopoeia (Ph. Eur.) recognizes units of measure Metric\nand Ph. Eur. sizes as equivalent, which is reflected on the labeling. The USP\nand Ph. Eur. sizes of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device are further\ndefined in Table 1.\n\n\n<table>\n<caption>Table 1. Diameter Comparison</caption>\n<tr>\n<th rowspan=\"2\">USP Device Size Designation</th>\n<th>Ph. Eur. Device Size</th>\n<th colspan=\"2\">STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus</th>\n</tr>\n<tr>\n<th>(Metric/Ph.Eur.) Designation</th>\n<th>USP</th>\n<th>Metric/ Ph. Eur.</th>\n</tr>\n<tr>\n<td>2-0</td>\n<td>3</td>\n<td>2-0</td>\n<td>3</td>\n</tr>\n<tr>\n<td>3-0</td>\n<td>2</td>\n<td>3-0</td>\n<td>2</td>\n</tr>\n<tr>\n<td>4-0</td>\n<td>1.5</td>\n<td>4-0</td>\n<td>1.5</td>\n</tr>\n</table>\n\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is intended for use only by\nhealthcare professionals who are trained in surgical suturing techniques\nincluding the use of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device.",
        "translated_back_chunk": "The European Pharmacopoeia (Ph. Eur.) recognizes metric units of measurement and Ph. Eur. sizes as equivalent, which is reflected in the labeling. The USP and Ph. Eur. sizes of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device are further defined in Table 1.\n\n\n<table>\n<caption>Table 1. Diameter Comparison</caption>\n<tr>\n<th rowspan=\"2\">USP Device Size Designation</th>\n<th>Ph. Eur. Device Size</th>\n<th colspan=\"2\">STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus</th>\n</tr>\n<tr>\n<th>Designation (Metric/Ph.Eur.)</th>\n<th>USP</th>\n<th>Metric/ Ph. Eur.</th>\n</tr>\n<tr>\n<td>2-0</td>\n<td>3</td>\n<td>2-0</td>\n<td>3</td>\n</tr>\n<tr>\n<td>3-0</td>\n<td>2</td>\n<td>3-0</td>\n<td>2</td>\n</tr>\n<tr>\n<td>4-0</td>\n<td>1.5</td>\n<td>4-0</td>\n<td>1.5</td>\n</tr>\n</table>\n\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is intended for use solely by healthcare professionals who are trained in surgical suturing techniques, including the use of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device.",
        "similarity_score": 0.9977
    },
    {
        "chunk_id": 5,
        "original_chunk": "Clinical benefits expected from soft tissue approximation are to promote wound\nhealing by primary intention.\n\nA summary of safety and clinical performance can be found at the following\nlink (upon activation): https://ec.europa.eu/tools/eudamed.\n\n\n## Tensile Strength\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device straight tensile strength is stronger\nthan the knot tensile strength for a USP and EU Pharmacopoeia poliglecaprone\n25 device of the equivalent size as shown in Table 2.\n\n\n<table>\n<caption>Table 2. Tensile Strength Comparison</caption>\n<tr>\n<th rowspan=\"2\">USP Device Size Designation</th>\n<th rowspan=\"2\">Ph. Eur. Device Size (Metric/ Ph. Eur.) Designation</th>\n<th colspan=\"2\">Device Minimum Knot Tensile Strength</th>\n</tr>\n<tr>\n<th>USP (kgf)</th>\n<th>Metric/ Ph. Eur. (N)</th>\n</tr>\n<tr>\n<td>2-0</td>\n<td>3</td>\n<td>2.68</td>\n<td>26.8</td>\n</tr>\n<tr>\n<td>3-0</td>\n<td>2</td>\n<td>1.77</td>\n<td>17.5</td>\n</tr>\n<tr>\n<td>4-0</td>\n<td>1.5</td>\n<td>0.95</td>\n<td>9.5</td>\n</tr>\n</table>",
        "translated_back_chunk": "The expected clinical benefits of soft tissue approximation are to promote wound healing by primary intention.\n\nA summary of safety and clinical performance can be found at the following link (when activated): https://ec.europa.eu/tools/eudamed.\n\n\n## Tensile Strength\n\nThe direct tensile strength of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is stronger than the knot tensile strength for a polyglecaprone 25 device of equivalent size from the USP and EU pharmacopoeia as shown in Table 2.",
        "similarity_score": 0.9686
    },
    {
        "chunk_id": 6,
        "original_chunk": "# Indications / Intended Use\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is indicated for use in soft tissue\napproximation where the use of absorbable sutures is appropriate.\n\n\n## Contraindications\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is not to be used where extended\napproximation of tissue under stress is required such as in fascia closure.\nThis device is not to be used in conjunction with or for fixation of prosthetic\ndevices (e.g., heart valves or synthetic grafts) that are non-absorbable in\nnature. STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device should not be used in\n\npatients with known allergic reactions (local hypersensitivity) to IRGACAREÂ®+\nMP (triclosan).\n\n\n### Warnings",
        "translated_back_chunk": "<table>\n<caption>Table 2. Comparison of Tensile Strength</caption>\n<tr>\n<th rowspan=\"2\">USP Device Size Designation</th>\n<th rowspan=\"2\">Device Size Designation (Metric/Ph. Eur.)</th>\n<th colspan=\"2\">Minimum Tensile Strength of the Device Knot</th>\n</tr>\n<tr>\n<th>USP (kgf)</th>\n<th>Metric/Ph. Eur. (N)</th>\n</tr>\n<tr>\n<td>2-0</td>\n<td>3</td>\n<td>2.68</td>\n<td>26.8</td>\n</tr>\n<tr>\n<td>3-0</td>\n<td>2</td>\n<td>1.77</td>\n<td>17.5</td>\n</tr>\n<tr>\n<td>4-0</td>\n<td>1.5</td>\n<td>0.95</td>\n<td>9.5</td>\n</tr>\n</table>\n\n\n# Directions / Intended Use\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is indicated for use in the approximation of soft tissues where the use of absorbable sutures is appropriate.\n\n\n## Contraindications",
        "similarity_score": 0.9007
    },
    {
        "chunk_id": 7,
        "original_chunk": "The safety and effectiveness of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device\nhave not been established in the following areas: fascial closures (including\nabdominal wall, thoracic and extremity fascial closures), gastrointestinal\nanastomoses, ophthalmic or microsurgery, cardiovascular, neural, osseous\nor tendinous tissue.\n\nHealthcare professionals should be familiar with surgical procedures and\ntechniques involving absorbable barbed device before employing STRATAFIXâ„¢\nSpiral MONOCRYLâ„¢ Plus Device for wound closure, as risk of tissue separation\n/ wound dehiscence leading to impaired healing may vary with the site\nof application and device material used. Healthcare professionals should\nconsider the in vivo performance (under the Performance / Actions section)\nwhen selecting a device for use in patients.\n\nAcceptable surgical practice should be followed for the management of\ncontaminated or infected wounds.",
        "translated_back_chunk": "The STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device should not be used where prolonged approximation of tissue under stress is required, such as in fascia closure. This device should not be used in conjunction with or for the fixation of prosthetic devices (for example, heart valves or synthetic grafts) that are non-absorbable by nature. The STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device should not be used in patients with known allergic reactions (local hypersensitivity) to IRGACAREÂ®+ MP (triclosan).\n\n\n### Warnings\n\nThe safety and efficacy of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device have not been established in the following areas: fascial closures (including abdominal wall, thoracic and limb fascial closures), gastrointestinal anastomosis, ophthalmic or cardiovascular microsurgery, neural, bone, or tendinous tissue.",
        "similarity_score": 0.9569
    },
    {
        "chunk_id": 8,
        "original_chunk": "As this is an absorbable device, the use of supplemental non-absorbable\nsutures should be considered by the healthcare professional in the closure of\nthe sites that may undergo expansion, stretching or distension, or that may\nrequire additional support.\n\nThe use of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device does not substitute\nnormal observance of hygiene and/or otherwise needed antibiotic treatment.\n\nHealthcare professionals should consider the quantity and quality of tissue in\nwhich the loop will be anchored. The use of this device may be inappropriate\nin highly vascularized tissue or fragile tissue that cannot withstand potential\nfurther tightening/constriction within the loop.\n\nSmall bowel obstruction (SBO): including volvulus, bowel infarction, and\nsignificant morbidity, have been reported due to barbs or barbed suture\nends hooking onto adjacent small bowel and/or mesentery, such as in\nperitoneal closure.",
        "translated_back_chunk": "Healthcare professionals should be familiar with surgical procedures and techniques involving absorbable devices with barbs before using the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus for wound closure, as the risk of tissue separation / wound dehiscence leading to poor healing may vary depending on the application site and the material of the device used. Healthcare professionals should consider the in vivo performance (under the Performance / Actions section) when selecting a device for use in patients.\n\nAn acceptable surgical practice for the management of contaminated or infected wounds should be followed.\n\nSince this is an absorbable device, the use of additional non-absorbable sutures should be considered by the healthcare professional in closing sites that may experience expansion, stretching, or distension, or that may require additional support.",
        "similarity_score": 0.9544
    },
    {
        "chunk_id": 9,
        "original_chunk": "Care should be undertaken to avoid leaving barbed suture ends adjacent to\nthe peritoneum in extra-peritoneal tissue closure.\n\nAvoid contacting STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device with other\nmaterials (e.g., surgical gauze, drapes, etc.) in the surgical field to prevent\nensnaring on the barbs. If the barbs catch, carefully pull the material in the\nopposite direction of the needle to disengage it from the barbs.\n\nDo not resterilize/reuse. Reuse of this device (or portions of this device)\nmay create a risk of product degradation that may result in device failure\nand/or cross-contamination that may lead to infection or transmission of\nblood-borne pathogens to patients and healthcare professionals.",
        "translated_back_chunk": "The use of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device does not replace the normal observance of hygiene and/or the otherwise necessary antibiotic treatment.\n\nHealthcare professionals should consider the quantity and quality of the tissue in which the loop will be anchored. The use of this device may be inappropriate in highly vascularized or fragile tissues that cannot withstand possible additional tightening/constriction within the loop.\n\nSmall Bowel Obstruction (SBO): including volvulus, intestinal infarction, and significant morbidity, have been reported due to barbs or barbed suture ends catching on the adjacent small intestine and/or mesentery, as in peritoneal closure.\n\nCare should be taken to avoid leaving barbed suture ends adjacent to the peritoneum in the closure of extra-peritoneal tissue.",
        "similarity_score": 0.9302
    },
    {
        "chunk_id": 10,
        "original_chunk": "As an absorbable device, this device may act transiently as a foreign body. As\nwith any foreign body, prolonged contact of any device with salt solutions,\nsuch as those found in the urinary or biliary tracts, may result in calculus\nformation. Like all foreign bodies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\nDevice may potentiate infection.\n\nDiscard unintentionally opened / partially used / used devices and packages.\n\n\n#### Precautions",
        "translated_back_chunk": "Avoid contact of the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device with other materials (for example, surgical sponges, surgical drapes, etc.) in the surgical field to prevent them from getting tangled in the barbs. If the barbs get caught, carefully pull the material in the opposite direction of the needle to disengage it from the barbs.\n\nDo not resterilize/reuse. Reusing this device (or parts of this device) may create a risk of product degradation which could result in device failure and/or cross-contamination that may lead to infection or transmission of blood-borne pathogens to patients and healthcare professionals.\n\nAs an absorbable device, this device may act temporarily as a foreign body. As with any foreign body, prolonged contact of any device with saline solutions, such as those found in the urinary or biliary tracts, may result in the formation of stones. Like all foreign bodies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device may promote infection.",
        "similarity_score": 0.94
    },
    {
        "chunk_id": 11,
        "original_chunk": "STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device contains a loop end and barbs to\nanchor tissues and does not require knots to secure the device. Tying of knots\non the barbed section of the device will damage the barbs and potentially\nreduce their effectiveness and may result in extended surgery time or\ntreatment failure and additional surgery. For the device to function properly,\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device must first be anchored by using\nthe fixation loop in robust tissue. Then subsequently engage the barbs\ninto the tissue in a standard closure pattern. When completing placement\nof the barbed segment in subcuticular tissue, take at least one additional\npass in the reverse direction to lock STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\nDevice in place.",
        "translated_back_chunk": "Dispose of devices and packages that have been unintentionally opened / partially used / used.\n\n\n#### Precautions\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device contains an end shaped like a loop and barbs to anchor tissues and does not require knots to secure the device. Tying knots in the barbed section of the device will damage the barbs and potentially reduce its effectiveness, possibly resulting in extended surgery time or treatment failure and additional surgery. For the device to function properly, the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus must first be anchored using the fixation loop in robust tissue. Then, hook the barbs into the tissue following a standard closure pattern. Upon completing the placement of the barbed segment in subcuticular tissue, perform at least one additional pass in the reverse direction to secure the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus in place.",
        "similarity_score": 0.9632
    },
    {
        "chunk_id": 12,
        "original_chunk": "Subcuticular devices should be placed as deeply as possible to minimize the\nerythema and induration normally associated with the absorption process.\nUnder some circumstances, notably orthopaedic procedures, immobilization\nof joints by external support may be employed at the discretion of the\nhealthcare professional. Consideration should be taken in the use of\nabsorbable devices in tissues with poor blood supply as device extrusion and\ndelayed absorption may occur.\n\nThis device may be inappropriate in elderly, malnourished or debilitated\npatients, or in patients suffering from conditions that may delay wound healing.\n\nIn handling this or any other device material, care should be taken to avoid\ndamage. Avoid crushing or crimping damage due to application of surgical\ninstruments such as forceps or needle holders. Do not attempt to remove\nmemory in the polymer by running fingers down the device material as this\ncan damage the barbs.",
        "translated_back_chunk": "Subcuticular devices should be placed as deeply as possible to minimize erythema and induration normally associated with the absorption process. Under some circumstances, notably in orthopedic procedures, immobilization of joints through external support may be employed at the discretion of the healthcare professional. The use of absorbable devices in tissues with poor blood supply should be considered since device extrusion and delayed absorption may occur.\n\nThis device may be inappropriate in elderly, malnourished, or weakened patients, or in patients suffering from conditions that may delay wound healing.\n\nWhen handling this or other device material, care must be taken to avoid damage. Avoid crush or pinch damage due to the application of surgical instruments such as forceps or needle holders. Do not attempt to remove the memory in the polymer by sliding your fingers over the device material, as this may damage the barbs.",
        "similarity_score": 0.9918
    },
    {
        "chunk_id": 13,
        "original_chunk": "Care should be taken to avoid damage when handling surgical needles.\nGrasp the needle in an area one-third (1/3) to one-half (1/2) of the distance\nfrom the attachment end to the point. Grasping in the point area could\nimpair the penetration performance and cause fracture of the needle.\nGrasping at the attachment end could cause bending or breakage.\nReshaping needles may cause them to lose strength and be less resistant\nto bending and breaking.\n\nHealthcare professionals should exercise caution when handling surgical\nneedles to avoid inadvertent needle stick injury that may result in transmission",
        "translated_back_chunk": "Care must be taken to avoid damage when handling surgical needles. Hold the needle in an area from one third (1/3) to half (1/2) of the distance from the joint end to the tip. Holding in the tip area could impair penetration performance and cause the needle to fracture. Holding at the joint end could cause bending or breaking. Reshaping needles can cause them to lose strength and be less resistant to bending and breaking.",
        "similarity_score": 0.9586
    },
    {
        "chunk_id": 14,
        "original_chunk": "of blood-borne pathogens from contaminated needles. Broken needles\nmay result in extended or additional surgeries or residual foreign bodies.\nIn the event of a product malfunction before use, such as a bent, broken or\ndetached needle, or device damage including barbs, the product should be\ndiscarded and a new one obtained to begin the procedure. In the event of\nproduct malfunction during use, it is up to the discretion of the healthcare\nprofessional whether to continue or discontinue usage of the product and how\nto complete the procedure. Refer to Application / Instructions for Use section\nfor instructions on removal of the device.\n\n\n# Adverse Reactions / Undesirable Side Effects",
        "translated_back_chunk": "Healthcare professionals should be cautious when handling surgical needles to avoid accidental needlestick injuries that could result in the transmission of bloodborne pathogens from contaminated needles. Broken needles can result in extended or additional surgeries or residual foreign bodies. In the case of product malfunction before use, such as a bent, broken, or detached needle, or damage to the device including burrs, the product should be discarded and a new one obtained to begin the procedure. In the case of product malfunction during use, it is at the discretion of the healthcare professional to decide whether to continue or discontinue the use of the product and how to complete the procedure. Refer to the Application / Instructions for Use section for instructions on how to dispose of the device.\n\n\n# Adverse Reactions / Undesired Side Effects",
        "similarity_score": 0.9687
    },
    {
        "chunk_id": 15,
        "original_chunk": "Adverse reactions associated with the use of this device include tissue\nseparation / wound dehiscence leading to impaired healing or failure to\nprovide adequate wound support in the closure of the sites where expansion,\nstretching, or distension occur, and in elderly, malnourished or debilitated\npatients or in patients suffering from other conditions that may delay wound\nhealing. Other associated adverse events include calculus formation in urinary\nor biliary tracts when prolonged contact with salt solutions such as urine or\nbile occurs, transient inflammatory tissue reaction, allergic reaction (local\nhypersensitivity) to IRGACAREÂ®+ MP (triclosan), and delayed absorption in\ntissue with poor blood supply. Transient local irritation and suture extrusion\nmay occur at the wound site when skin sutures are left in place for greater\nthan 7 days. Like all foreign bodies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\nDevice may potentiate infection.",
        "translated_back_chunk": "Adverse reactions associated with the use of this device include tissue separation / wound dehiscence leading to impaired healing or the inability to provide adequate wound support at closure sites where expansion, stretching, or distension occurs, and in elderly, malnourished or weakened patients, or in patients suffering from other conditions that may delay wound healing. Other associated adverse events include the formation of stones in the urinary or biliary tracts when there is prolonged contact with saline solutions such as urine or bile, transient inflammatory tissue reaction, allergic reaction (local hypersensitivity) to IRGACAREÂ®+ MP (triclosan), and delayed absorption in tissues with poor blood supply. Transient local irritation and suture extrusion at the wound site may occur when cutaneous sutures are left in place for more than 7 days.\n\ndays. Like all foreign bodies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device may promote infection.",
        "similarity_score": 0.9867
    },
    {
        "chunk_id": 16,
        "original_chunk": "Device breakage may result in hemorrhage. Improper use of the device may\ncause soft tissue injury. Damage to device during use can cause extended\nsurgery time or treatment failure and additional surgery.\n\nBroken needles may result in extended or additional surgeries or residual\nforeign bodies. Inadvertent needle sticks with contaminated surgical\nneedles may result in the transmission of blood-borne pathogens.\n\nHealthcare professionals should convey adverse reactions, undesirable\nside effects and risks associated with the product and the procedure to the\npatient and advise the patient to contact a healthcare professional in case of\nany deviation from the normal postoperative course.\n\nAny serious incident that has occurred in relation to the device should be\nreported to the manufacturer and the country-competent authority.\n\n\n## Magnetic Resonance Imaging (MRI) / Carcinogenic, Mutagenic, Toxic to Reproduction (CMR)/ Endocrine Disrupting (ED) Safety Information",
        "translated_back_chunk": "The breakage of the device may result in bleeding. Improper use of the device can cause soft tissue injuries. Damage to the device during use may lead to prolonged surgery time or treatment failure and additional surgeries.\n\nBroken needles may result in prolonged or additional surgeries or residual foreign bodies. Accidental punctures with contaminated surgical needles may result in the transmission of blood-borne pathogens.\n\nHealthcare professionals should communicate adverse reactions, undesirable side effects, and risks associated with the product and procedure to the patient and advise the patient to contact a healthcare professional in case of any deviation from the normal postoperative course.\n\nAny serious incident that has occurred in relation to the device must be reported to the manufacturer and to the competent authority of the country.",
        "similarity_score": 0.9188
    },
    {
        "chunk_id": 17,
        "original_chunk": "STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is MR safe. No known CMR\nCategory 1a/1b and ED substances are present at >0.1%. Category 1a/1b\nare defined as known or presumed human carcinogen (H340), mutagen\n(H350) or reproductive toxicant (H360), based on human evidence and\nanimal studies.\n\n\n### Application / Instructions for Use\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device should be selected and implanted\ndepending on patient condition, surgical experience, surgical technique and\nwound characteristics.\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is designed to be used in\ncontinuous suture patterns and is intended to be used without anchoring\nknots to begin or terminate the device line.\nUse as required per surgical procedure.\n\n1\\. Secure the fixation loop portion to robust tissue by taking a bite in the\ndesignated tissue, passing the needle through the loop and pulling tautly\naround the anchoring tissue.",
        "translated_back_chunk": "## Safety Information on Magnetic Resonance Imaging (MRI) / Carcinogenic, Mutagenic, Reproductive Toxicant (CMR) / Endocrine Disruptor (ED)\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is safe for MRI. There are no known CMR substances of Category 1a/1b and ED present in >0.1%. Categories 1a/1b are defined as known or presumed human carcinogens (H340), mutagens (H350), or reproductive toxicants (H360), based on human evidence and animal studies.\n\n\n### Application / Instructions for Use\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device should be selected and implanted depending on the patient's condition, surgical experience, surgical technique, and wound characteristics.\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is designed for use in continuous suture patterns and is intended to be used without anchoring knots to start or end the device line.\nUse as needed by surgical procedure.",
        "similarity_score": 0.9633
    },
    {
        "chunk_id": 18,
        "original_chunk": "2\\. After STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is anchored into the\ntissue, grasp the strand and approximate tissue to the desired tension.\nBites, or passes through the tissue, can be taken in a continuous\nsuturing technique to approximate the wound. Care should be taken\nto utilize STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device on the barbed\nsegments only. Do not attempt to approximate wounds using the\nnon-barbed segment near the needle, as the barbs are required for\nsuccessful wound approximation with STRATAFIXâ„¢ Spiral MONOCRYLâ„¢\nPlus Device.\n\n3\\. a. To complete the closure in subcuticular closure, take at least one pass\nin the reverse direction. Then pass the needle across the incision and\ntake a split-thickness bite perpendicular to the incision and exit the skin.\nb. To complete the closure in all other tissue layers, take at least two\npasses in the reverse direction to complete the closure.",
        "translated_back_chunk": "1. Secure the loop fixation part to the robust tissue by taking a bite in the designated tissue, passing the needle through the loop, and pulling firmly around the anchoring tissue.\n\n2. After the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is anchored in the tissue, hold the strand and bring the tissue to the desired tension. Bites or passes can be made through the tissue using a continuous suturing technique to approximate the wound. Care must be taken to use the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device only on the segments with barbs. Do not attempt to approximate wounds using the barbless segment near the needle, as the barbs are necessary for a successful wound approximation with the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device.",
        "similarity_score": 0.9645
    },
    {
        "chunk_id": 19,
        "original_chunk": "4\\. Then gently pull on the free end of the device and cut flush with\nthe surface of the tissue.\n\nTo remove the entire STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device: Cut\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device at the end anchored with the\nloop, and then pull the distal end to remove the device.\n\nDiscard needles in \"sharps\" containers. Discard unintentionally opened\n/ partially used / used devices and packages according to your facility's\npolicies and procedures concerning biohazardous materials and waste.\n\n\n# Performance / Actions",
        "translated_back_chunk": "3. a. To complete the closure in a subcuticular closure, make at least one pass in the reverse direction. Then pass the needle through the incision and take a partial thickness bite perpendicular to the incision and exit the skin.\nb. To complete the closure in all other tissue layers, make at least two passes in the reverse direction to complete the closure.\n\n4. Then gently pull the free end of the device and cut it flush with the tissue surface.\n\nTo remove the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device: Cut the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device at the anchored end with the loop, and then pull the distal end to remove the device.\n\nDispose of needles in sharps containers. Dispose of devices and packages that have been unintentionally opened / partially used / used in accordance with the policies and procedures of your facility regarding biocontaminated materials and waste.\n\n\n# Performance / Actions",
        "similarity_score": 0.9422
    },
    {
        "chunk_id": 20,
        "original_chunk": "The results of implantation studies in animals using STRATAFIXâ„¢ Spiral\nMONOCRYLâ„¢ Plus Device indicate that approximately 62% of its original\nstrength remains after 7 days implantation and approximately 27% of its\noriginal tensile strength at 14 days post implantation (Table 3). All the\noriginal tensile strength is lost by 21 days post implantation. Absorption\nbegins as loss of tensile strength followed by a loss of mass. Absorption is\nessentially complete between 91 and 119 days.\n\n\n<table>\n<caption>Table 3. In Vivo Tensile Strength Profile</caption>\n<tr>\n<th>Days Implantation</th>\n<th>Approximate Original Strength Remaining</th>\n</tr>\n<tr>\n<td>7 Days</td>\n<td>62% of USP knot tensile strength</td>\n</tr>\n<tr>\n<td>14 Days</td>\n<td>27% of USP knot tensile strength</td>\n</tr>\n</table>",
        "translated_back_chunk": "The results of animal implantation studies using STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device indicate that approximately 62% of its original strength remains after 7 days of implantation and approximately 27% of its original tensile strength at 14 days after implantation (Table 3). All original tensile strength is lost by 21 days after implantation. Absorption begins as loss of tensile strength followed by a loss of mass. Absorption is essentially complete between 91 and 119 days.\n\n\n<table>\n<caption>Table 3. In Vivo Tensile Strength Profile</caption>\n<tr>\n<th>Days of Implantation</th>\n<th>Approximate Remaining Original Strength</th>\n</tr>\n<tr>\n<td>7 Days</td>\n<td>62% of the USP knot tensile strength</td>\n</tr>\n<tr>\n<td>14 Days</td>\n<td>27% of the USP knot tensile strength</td>\n</tr>\n</table>",
        "similarity_score": 0.9965
    },
    {
        "chunk_id": 21,
        "original_chunk": "Using in vitro studies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device has\nbeen shown to inhibit colonization of the device by Staphylococcus aureus,\nStaphylococcus epidermidis, methicillin-resistant S. aureus, methicillin-\nresistant S. epidermidis, Escherichia coli, and Klebsiella pneumoniae, which\nare microorganisms known to be associated with surgical site infections.\nAnimal studies have demonstrated that STRATAFIXâ„¢ Spiral MONOCRYLâ„¢\nPlus Device inhibits bacterial colonization of the device after direct in vivo\nchallenge with bacteria.\n\n\n## Sterility\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is sterilized by ethylene oxide\ngas. Do not resterilize. Do not use if package is opened or damaged.\n\n\n### Storage\n\nStore at or below 30â„ƒ (86ÂºF). If the product is exposed outside specified\nstorage range, contact manufacturer. Do not use after expiry date.\n\n\n### How Supplied",
        "translated_back_chunk": "Using in vitro studies, the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device has demonstrated inhibition of device colonization by Staphylococcus aureus, Staphylococcus epidermidis, methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, Escherichia coli, and Klebsiella pneumoniae, which are microorganisms known to be associated with surgical site infections. Animal studies have shown that the STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device inhibits bacterial colonization of the device after a direct in vivo challenge with bacteria.\n\n\n## Sterility\n\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is sterilized with ethylene oxide gas. Do not resterilize. Do not use if the package is open or damaged.\n\n\n### Storage\n\nStore at 30Â°C (86Â°F) or less. If the product is exposed outside the specified storage range, contact the manufacturer. Do not use after the expiration date.\n\n\n### How it is Supplied",
        "similarity_score": 0.9953
    },
    {
        "chunk_id": 22,
        "original_chunk": "STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available sterile, undyed in\nsizes 4-0 through 2-0 (metric sizes 1.5-3.0), in a variety of lengths, with\npermanently attached single armed needles.\n\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available in one dozen units\nper box.\n\n\n### Traceability\n\nThe following specific information can be found on the device packaging label:\nCatalogue number, Batch Code, expiry and manufacturing date, manufacturer\nname, address and the website and a Unique Device Identification bar code\nwith the Global Trade Item Number information.\n\n*Registered Trademark of BASF Group",
        "translated_back_chunk": "The STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is available sterile, undyed in sizes from 4-0 to 2-0 (metric sizes 1.5-3.0), in a variety of lengths, with permanently attached single-arm needles.\n\nThe STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus device is available in units of a dozen per box.\n\n\n### Traceability\n\nThe following specific information can be found on the device packaging label:\nCatalog number, batch code, expiration date and manufacturing date, manufacturer's name, address and website, and a barcode for Unique Device Identification with information on the Global Trade Item Number.\n\n*Registered Trademark of BASF Group",
        "similarity_score": 0.992
    }
]